Journal article

Cerebral palsy

H Kerr Graham, Peter Rosenbaum, Nigel Paneth, Bernard Dan, Jean-Pierre Lin, Diane L Damiano, Jules G Becher, Deborah Gaebler-Spira, Allan Colver, DinahS Reddihough, Kylie E Crompton, Richard L Lieber



Cerebral palsy is the most common cause of childhood-onset, lifelong physical disability in most countries, affecting about 1 in 500 neonates with an estimated prevalence of 17 million people worldwide. Cerebral palsy is not a disease entity in the traditional sense but a clinical description of children who share features of a non-progressive brain injury or lesion acquired during the antenatal, perinatal or early postnatal period. The clinical manifestations of cerebral palsy vary greatly in the type of movement disorder, the degree of functional ability and limitation and the affected parts of the body. There is currently no cure, but progress is being made in both the prevention and the ..

View full abstract


Awarded by Guy's and St. Thomas Charity New Services and Innovation Grant

Awarded by Dystonia Society UK

Awarded by Action Medical Research

Funding Acknowledgements

H.K.G. has received unrestricted educational grants from pharmaceutical companies including Allergan. Current research support is from the Hugh Williamson Foundation and the National Health and Medical Research Council of Australia, Cerebral Palsy Centre of Research Excellence (CRE). J.-P.L. has held grants from the Guy's and St. Thomas Charity New Services and Innovation Grant G060708; the Dystonia Society UK Grants 01/2011 and 07/2013 and Action Medical Research GN2097, has acted as a consultant for Medtronic Ltd and benefited from unrestricted educational grants by Medtronic Ltd. B.D. and P.R. are senior members of the editorial board of Mac Keith Press, the publisher of the 2014 book "Cerebral Palsy: Science and Clinical Practice" (Mac Keith Press: London) and have contributed to several chapters, for which they are likely to receive modest royalties. All other authors declare no competing interests.